Pharmaceutical composition useful for reducing rapid degradation of the active ingredient comprises clavulanate, in the form of granulated and hydrophobised particles, and an active ingredient

A pharmaceutical composition comprises clavulanate and an active ingredient. The clavulanate is in the form of granulated and hydrophobised particles. ACTIVITY : Antibiotic. MECHANISM OF ACTION : Lactamase-Inhibitor-Beta.

Saved in:
Bibliographic Details
Main Authors DAEMON OTTO, VEIGL ROBERT, JENNEWEIN HERWIG DR, LENTNER THOMAS, SCHWARZ FRANZ XAVER
Format Patent
LanguageEnglish
German
Published 15.08.2006
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A pharmaceutical composition comprises clavulanate and an active ingredient. The clavulanate is in the form of granulated and hydrophobised particles. ACTIVITY : Antibiotic. MECHANISM OF ACTION : Lactamase-Inhibitor-Beta.
Bibliography:Application Number: AT20010000595